FDS´s unique strategyA unique strategy to treating neurodegenerative disorders called "Total Brain Health" will be applied by FSD Pharma through the acquisition of Lucid Pharmaceuticals, which will enter the medical psychedelics market. Although it is an early stage industry, the potential of psychedelic health care is growing, and the market is expected to reach 10.75 billion US dollars by 2027.